CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
- Digital Object Identifier
- https://doi.org/10.1016/j.annonc.2021.07.005
- Open Access
- http://aura.abdn.ac.uk/bitstreams/3fa815b0-d34e-41dc-b337-d9467ebc3716/download
- Additional Links
- View publication in Scopus